Franklin Resources’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26M | Buy |
39,855
+1,897
| +5% | +$59.8K | ﹤0.01% | 1892 |
|
|
2025
Q1 | $1.24M | Buy |
37,958
+6,350
| +20% | +$208K | ﹤0.01% | 1858 |
|
|
2024
Q4 | $1.14M | Buy |
31,608
+1,627
| +5% | +$58.8K | ﹤0.01% | 1923 |
|
|
2024
Q3 | $987K | Buy |
29,981
+2,121
| +8% | +$69.8K | ﹤0.01% | 1983 |
|
|
2024
Q2 | $745K | Buy |
27,860
+3,217
| +13% | +$86.1K | ﹤0.01% | 2054 |
|
|
2024
Q1 | $841K | Sell |
24,643
-1,073
| -4% | -$36.6K | ﹤0.01% | 2013 |
|
|
2023
Q4 | $744K | Sell |
25,716
-3,102
| -11% | -$89.8K | ﹤0.01% | 1764 |
|
|
2023
Q3 | $795K | Sell |
28,818
-387
| -1% | -$10.7K | ﹤0.01% | 1695 |
|
|
2023
Q2 | $878K | Buy |
29,205
+23,624
| +423% | +$710K | ﹤0.01% | 1686 |
|
|
2023
Q1 | $202K | Buy |
+5,581
| New | +$202K | ﹤0.01% | 1997 |
|